No description
-
2015 (v1)PublicationUploaded on: April 14, 2023
-
2015 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2015 (v1)Publication
In vitro and animal studies point to autoantibodies against apolipoproteinA-1 (anti-apoA-1 IgG) as possible mediators of cardiovascular disease involving several mechanisms, such as basal heart rate interference mediated by a mineralocorticoid receptor (MR)-dependent L-type calcium channel activation, and a direct pro-inflammatory effect...
Uploaded on: April 14, 2023 -
2017 (v1)PublicationAnti-apolipoprotein A-1 IgG predict all-cause mortality and are associated with FCRL3 polymorphisms.
No description
Uploaded on: April 14, 2023 -
2015 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2015 (v1)Publication
Auto-antibodies to apolipoprotein A-1 (anti-apoA-1 IgG) were shown to promote inflammation and atherogenesis, possibly through innate immune receptors signalling. Here, we aimed at investigating the role of Toll-like receptors (TLR) 2 and 4 on anti-apoA-1 IgG-induced atherosclerotic plaque vulnerability, myocardial necrosis and mortality in...
Uploaded on: April 14, 2023